In clinical trials, non-diabetic individuals taking semaglutide experienced significant weight loss, with average weight loss ranging from 10% to 15% of initial body weight over 6-12 months of treatment
July 29, 2019
And even when patients start taking these medicines, a meaningful number experience uncomfortable side effects that make their weight loss journeys challenging
Funding This research was funded by the National Natural Science Foundation of China (82130109, 81773924, 81573636), and Beijing Natural Science Foundation (7182114)
Shirley Niveta, Cordelia Mano John, Sumathy Arockiasamy Molecular Biology Reports.2024;[Epub] CrossRef The obesity-autophagy-cancer axis: Mechanistic insights and therapeutic perspectives Amir Barzegar Behrooz, Marco Cordani, Alessandra Fiore, Massimo Donadelli, Joseph W